HepaGam B® [Hepatitis B Immunoglobulin Intravenous (Human)]


HepaGam B® [Hepatitis B Immunoglobulin (Human)] Sterile Solution for Injection

The following information is available in .pdf

Canadian Product Monographs:


HepaGam B® Product Inquiries:

Tel: +972-8-9406472

Reporting Suspected Side Effects

To report SUSPECTED ADVERSE REACTIONS contact Pharmaceuticals Therapeutics at +972-8-9406472 or you can report any suspected adverse reaction associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

  • Report online at www.healthcanada.gc.ca/medeffect
  • Call toll-free at 1-866-234-2345
  • Complete a Canada Vigilance Reporting Form and:
    • Fax toll-free to 1-866-678-6789, or
    • Mail to: Canada Vigilance Program
      Health Canada
      Postal Locator 0701D
      Ottawa, Ontario
      K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at www.healthcanada.gc.ca/medeffect.

HepaGam B® [Hepatitis B Immunoglobulin Intravenous (Human)] and all Kamada brand, product, service and feature names, logos, and slogans are trademarks or registered trademarks of Kamada in the United States and/or other countries. Copyright 2019 Kamada Pharmaceuticals. All rights reserved.